Related topics: brain
Schizophrenia
hideSchizophrenia (SCZ) (pronounced /ˌskɪtsɵˈfrɛniə/ or /ˌskɪtsɵˈfriːniə/), from the Greek roots skhizein (σχίζειν, "to split") and phrēn, phren- (φρήν, φρεν-; "mind") is a psychiatric diagnosis that describes a mental disorder characterized by abnormalities in the perception or expression of reality. Distortions in perception may affect all five senses, including sight, hearing, taste, smell and touch, but most commonly manifest as auditory hallucinations, paranoid or bizarre delusions, or disorganized speech and thinking with significant social or occupational dysfunction. Onset of symptoms typically occurs in young adulthood, with approximately 0.4–0.6% of the population affected. Diagnosis is based on the patient's self-reported experiences and observed behavior. No laboratory test for schizophrenia currently exists.
Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Current psychiatric research is focused on the role of neurobiology, but no single organic cause has been found. Due to the many possible combinations of symptoms, there is debate about whether the diagnosis represents a single disorder or a number of discrete syndromes. For this reason, Eugen Bleuler termed the disease the schizophrenias (plural) when he coined the name. Despite its etymology, schizophrenia is not the same as dissociative identity disorder, previously known as multiple personality disorder or split personality, with which it has been erroneously confused.
Increased dopamine activity in the mesolimbic pathway of the brain is consistently found in schizophrenic individuals. The mainstay of treatment is antipsychotic medication; this type of drug primarily works by suppressing dopamine activity. Dosages of antipsychotics are generally lower than in the early decades of their use. Psychotherapy, and vocational and social rehabilitation are also important. In more serious cases—where there is risk to self and others—involuntary hospitalization may be necessary, although hospital stays are less frequent and for shorter periods than they were in previous times.
The disorder is thought to mainly affect cognition, but it also usually contributes to chronic problems with behavior and emotion. People with schizophrenia are likely to have additional (comorbid) conditions, including major depression and anxiety disorders; the lifetime occurrence of substance abuse is around 40%. Social problems, such as long-term unemployment, poverty and homelessness, are common. Furthermore, the average life expectancy of people with the disorder is 10 to 12 years less than those without, due to increased physical health problems and a higher suicide rate.
For more information about Schizophrenia, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with schizophrenia
Research backs theory on autism, schizophrenia
Nov 30, 2009 |
3.9 / 5 (11) |
3
(PhysOrg.com) -- New research by Simon Fraser University evolutionary biologist Bernard Crespi reinforces his theory that autism and schizophrenia are diametric or opposite conditions based on genes.
Search results for schizophrenia
Scientists discover a controller of brain circuitry
Medicine & Health / Neuroscience
Dec 28, 2009 |
4.9 / 5 (16) |
2
By combining a research technique that dates back 136 years with modern molecular genetics, a Johns Hopkins neuroscientist has been able to see how a mammal's brain shrewdly revisits and reuses the same molecular ...
Schizophrenia mouse model should improve understanding and treatment of the disorder
Dec 28, 2009 |
4 / 5 (4) |
1
Scientists have created what appears to be a schizophrenic mouse by reducing the inhibition of brain cells involved in complex reasoning and decisions about appropriate social behavior.
Emerald BioStructures announces discovery of small molecule modulators of PDE4
Dec 27, 2009 |
not rated yet |
0
Emerald BioStructures (formerly deCODE biostructures) announced a publication in the December 27, 2009 advance online issue of Nature Biotechnology, detailing the application of structure-based drug design (SBDD) to engine ...
New study links DHA type of omega-3 to better nervous-system function
Medicine & Health / Neuroscience
Dec 16, 2009 |
5 / 5 (1) |
0
The omega-3 essential fatty acids commonly found in fatty fish and algae help animals avoid sensory overload, according to research published by the American Psychological Association. The finding connects low omega-3s to ...
Scientists suggest certain genes boost chances for distributing variety of traits, drive evolution
Dec 14, 2009 |
not rated yet |
0
Genes that don't themselves directly affect the inherited characteristics of an organism but leave them increasingly open to variation may be a significant driving force of evolution, say two Johns Hopkins scientists.
New biosensors reveal workings of anti-psychotic drugs in the living brain
Medicine & Health / Neuroscience
Dec 13, 2009 |
4 / 5 (3) |
0
Scientists have resolved a question about how a popular class of drugs used to treat schizophrenia works using biosensors that reveal previously hidden components of chemical communication in the brain.
Major impacts of climate change expected on mental health
Medicine & Health / Psychology & Psychiatry
Dec 03, 2009 |
3.4 / 5 (5) |
12
Leading mental health researchers are warning that some of the most important health consequences of climate change will be on mental health, yet this issue is unlikely to be given much attention at the UN climate change ...
New safety concern related to antipsychotic treatment
Medicine & Health / Psychology & Psychiatry
Dec 01, 2009 |
not rated yet |
1
Overall, antipsychotic medications are reasonably effective, and fairly well tolerated treatments for mood and psychotic disorders. However, treatment with a number of antipsychotic medications is associated with weight ...
List of search results for schizophrenia


